Assyro AI

Orange Book product · Generic (ANDA)

OSELTAMIVIR PHOSPHATE

OSELTAMIVIR PHOSPHATE

Generic (ANDA)ANDA 210157DISCN RISING
View OSELTAMIVIR PHOSPHATE familyOpen on FDA Orange Book

At a glance

Jan 21, 2021

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 21, 2021

    5 yr 6 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

OSELTAMIVIR PHOSPHATE

Strength

EQ 30MG BASE

Dosage form

CAPSULE

Route

ORAL

TE code

Not listed

Application

ANDA 210157

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of OSELTAMIVIR PHOSPHATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo